Eye drops and preparation method thereof

The invention discloses eye drops and a preparation method thereof, the eye drops comprise an agent A and an agent B which are independently packaged, the agent A takes taurine or pharmaceutically acceptable salt thereof as an active ingredient, and the agent B takes atropine or pharmaceutically acc...

Full description

Saved in:
Bibliographic Details
Main Authors YANG WENPING, ZHANG JIANAN, LIANG HONGCHUN, YU WENTING, SONG XIANDONG, SUN TAO, SONG XIANXU, LI HONGHAI
Format Patent
LanguageChinese
English
Published 02.08.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention discloses eye drops and a preparation method thereof, the eye drops comprise an agent A and an agent B which are independently packaged, the agent A takes taurine or pharmaceutically acceptable salt thereof as an active ingredient, and the agent B takes atropine or pharmaceutically acceptable salt thereof as an active ingredient. Based on clinical nursing practice, the taurine eye drops and the atropine sulfate eye drops are used in a matched mode for patients suffering from the dry eye syndrome after the cataract operation, uncomfortable symptoms such as eye dryness and eye acerbity of the patients suffering from the dry eye syndrome after the cataract operation are obviously relieved, the eye drops are convenient to use, nursing pressure on the patients can be fully relieved, and the eye drops are suitable for clinical application. The method is suitable for clinical application and popularization. 本发明公开了一种滴眼液及其制备方法，所述滴眼液中包括独立包装的A剂和B剂，其中，A剂中以牛磺酸或其药学上可接受的盐为活性成分，B剂以阿托品或其药学上可接受的盐为活性成分。本发明基于临床护理实践
Bibliography:Application Number: CN202210629869